plumbagin has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, KJ; Kim, J; Kim, SA; Lee, Y | 1 |
1 other study(ies) available for plumbagin and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; DNA Primers; Flow Cytometry; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lipopolysaccharides; Naphthoquinones; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Transcription, Genetic | 2016 |